Nipride Rtu Injection, Solution
Product Images NDC 51754-1029

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nipride Rtu (NDC 51754-1029). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exela Pharma Sciences, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

NIPRIDE RTU sodium nitroprusside injection, 0.2 mg/mL strength (10 mg/50 mL), in a 50 mL single dose vial. The label states it is for intravenous infusion only and ready to use. Manufactured and distributed by Exela Pharma Sciences, LLC, Lenoir, NC. Includes storage instructions to protect from light and store at controlled room temperature.*

FDA Label Image

Image 02

NIPRIDE RTU 0.2 mg/mL sodium nitroprusside in 0.9% sodium chloride injection, ready-to-use solution. The label shows a 10 mg/50 mL vial for intravenous infusion, single dose. Manufactured and distributed by EXELA PHARMA SCIENCES, LLC. Storage instructions: protect from light, store at 20 to 25°C. Includes barcode and lot/expiration date fields.*

FDA Label Image

Image 03

Label for NIPRIDE RTU Sodium Nitroprusside in 0.9% Sodium Chloride Injection at a concentration of 50 mg/100 mL (0.5 mg/mL). This is a 100 mL single dose vial for intravenous infusion only, by Exela Pharma Sciences, LLC. The label includes storage instructions, barcode, and prescription use indication.*

FDA Label Image

Image 04

NIPRIDE RTU 0.2 mg/mL sodium nitroprusside in 0.9% sodium chloride injection vial label. The label states it is ready to use for intravenous infusion only, with a 100 mL single dose vial. It includes storage instructions, manufacturer EXELA PHARMA SCIENCES, LLC, and a barcode.*

FDA Label Image

Image 05

NIPRIDE RTU 0.5 mg/mL (50 mg/100 mL) sodium nitroprusside in 0.9% sodium chloride injection box label for a 100 mL single dose vial. The label specifies it is for intravenous infusion only, ready to use, and Rx only. Manufactured and distributed by Exela Pharma Sciences, LLC. Storage and usage instructions are included.*

FDA Label Image

Image 06

NIPRIDE RTU 0.2 mg/mL Sodium Nitroprusside Injection in 0.9% Sodium Chloride, 100 mL single dose vial packaging label by EXELA PHARMA SCIENCES, LLC. The label includes storage instructions, dosage strength, and notes that the product is for intravenous infusion only and to discard unused portions.*

FDA Label Image

Image Description (Spl Image1 Structure)

Chemical structure of sodium nitroprusside depicting an iron (Fe) center coordinated to five cyanide (C≡N) groups and one nitrosyl (NO) group, with two sodium (Na+) ions and two water (H2O) molecules associated.*

FDA Label Image

Image Description (Spl Image2 Metabolism Flow)

Illustration diagram depicting the metabolism of sodium nitroprusside. It shows biochemical pathways including the conversion of nitroprusside to cyanide and cyanmethemoglobin, interactions with active and inactive cytochromes, and the breakdown to thiocyanate and thiosulfate, with renal excretion pathways indicated.*

FDA Label Image

Image Description (Spl Image3 Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.